<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346885</article-id>
      <article-id pub-id-type="pmc">3876019</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132245</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Systemic sclerosis with keloidal nodules<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Esclerose sist&#xEA;mica com n&#xF3;dulos queloidianos</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Stadler</surname>
            <given-names>B&#xE1;rbara</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Somacal</surname>
            <given-names>Aline Paula Biazus</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weingraber</surname>
            <given-names>Emilio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fontana</surname>
            <given-names>Michelle Tokarski</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Skare</surname>
            <given-names>Thelma Larocca</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, Resident in Rheumatology. Rheumatology Unit, Hospital Universit&#xE1;rio
Evang&#xE9;lico de Curitiba - Faculdade Evang&#xE9;lica do Paran&#xE1; (HUEC-FEPAR) - Curitiba (PR),
Brasil.</aff>
      <aff id="aff02"><label>2</label> MD, Resident in Dermatology. Dermatotology Unit, Hospital Universit&#xE1;rio
Evang&#xE9;lico de Curitiba - Faculdade Evang&#xE9;lica do Paran&#xE1; (HUEC-FEPAR) - Curitiba (PR),
Brasil.</aff>
      <aff id="aff03"><label>3</label> MD. Professor in Dermatology. Residence tutor in Dermatology - Hospital
Universit&#xE1;rio Evang&#xE9;lico de Curitiba - Faculdade Evang&#xE9;lica do Paran&#xE1; (HUEC-FEPAR) -
Curitiba (PR), Brasil.</aff>
      <aff id="aff04"><label>4</label> MD, PhD. Rheumatology professor at the Faculdade Evang&#xE9;lica do Paran&#xE1;
(FEPAR) - Curitiba (PR), Brasil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Thelma Larocca Skar, Rua: Sete de Setembro, 4713, 80240
000 - Curitiba - PR, Brazil. E-mail: <email>tskare@onda.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>75</fpage>
      <lpage>77</lpage>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>12</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Nodular sclerosis is a rare form of presentation related to both systemic and
localized forms of scleroderma. We describe the case of a patient with nodular
sclerosis in order to alert the medical community to recognize this entity.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Esclerose nodular &#xE9; uma forma de apresenta&#xE7;&#xE3;o cut&#xE2;nea rara relacionada tanto com a
forma sist&#xEA;mica como com a forma localizada da esclerodermia. Descrevemos aqui o caso
de uma paciente esta forma nodular de esclerose, no sentido de alertar a comunidade
m&#xE9;dica para o reconhecimento dessa entidade.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Keloid</kwd>
        <kwd>Scleroderma, diffuse</kwd>
        <kwd>Scleroderma, limited</kwd>
        <kwd>Scleroderma, localized</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Systemic sclerosis or scleroderma (SSc) is an autoimmune inflammatory disease
characterized by localized or diffuse cutaneous thickening, pulmonary fibrosis,
pulmonary hypertension and swallowing disorders among others.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Raynaud's phenomenon is a common finding, which may
precede the disease in years.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> In its
localized form, this is a disease limited to the skin and it can take the form of a
plaque, linear lesion or hemiatrophy, etc.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Nodular sclerosis is a rare form of SSc, secondary to an excessive fibrosing reaction
and leading to the appearance of multiple cutaneous nodules, similar to
keloids.<sup><xref ref-type="bibr" rid="r02">2</xref>-<xref ref-type="bibr" rid="r09">9</xref></sup> We describe here a case of nodular scleroderma or
keloidal scleroderma in a woman of 44 years. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 44 years old female patient of afro-descendant origin seeks medical help with a 12
years history of Raynaud's phenomenon associated with painful digital ulcers. Six years
ago she developed arthralgia in both hands, alopecia and dyspnea on exertion. One year
ago she noted skin lesions "similar to keloid", of approximately 2 to 3 cm in trunk,
back and neck that gradually increased in number. Prior treatment with local
corticosteroid injections was done without any improvement. </p>
      <p>On physical examination she had microstomia, narrowing of hand fingertips with small
scars and an active ulcer in 2<sup>nd</sup> right finger of 5 mm. Skin thickness was
seen in skin of the hands forearms and face. In the regions of the neck, trunk and back
she had numerous nodular lesions, 2 to 3 cm in diameter, not painful (<xref ref-type="fig" rid="f01">Figure 1</xref>). Heart, lung and abdomen examinations were
normal. A periungueal capillaroscopy was performed and showed a SD pattern (SD=systemic
sclerosis pattern). Radiographs of hands, echocardiography, barium swallow and CT of the
chest were normal. A respiratory function test showed restrictive ventilatory defect.
Laboratory showed a positive ANA (1/640; with fine speckled pattern) and negatives tests
for antiScl-70 and anti-centromere. Sedimentation rate, C reactive protein, complete
blood count, liver and kidney function tests were normal.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>
<bold>A.</bold> Region upper chest showing firm and elastic nodules;
<bold>B.</bold> Close view of nodules</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0075-g01"/>
      </fig>
      <p>The patient underwent biopsy of two nodular lesions in the chest, which findings are
shown at <xref ref-type="fig" rid="f02">Figures 2</xref> and <xref ref-type="fig" rid="f03">3</xref>. In <xref ref-type="fig" rid="f02">Figure 2A</xref> and <xref ref-type="fig" rid="f02">2B</xref>, it can be seen that the epidermis presents with
acanthosis and hyperpigmentation at basal layer. Superficial dermis is preserved and
reticular dermis has increased thickness and sclerosis of collagen bundles. Collagen
fibers exhibit parallel distribution. There is, also, a discrete perivascular
inflammatory process. The interstices between collagen fibers is decreased and there is
entrapment of eccrine glands and nerves. (<xref ref-type="fig" rid="f02">Figures
2A</xref> and <xref ref-type="fig" rid="f02">B</xref>). In the <xref ref-type="fig" rid="f03">Figure 3</xref> elastic fibers (darker) can be seen. They do not exist in
keloids. </p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>
<bold>A.</bold> Histological aspect of the anterior chest nodule showing epidermis
with mild acanthosis and basal layer hyperpigmentation; preserved superficial
dermis, reticular dermis with sclerosis of collagen bundles and increased
thickness and discrete perivascular inflammatory infiltrate. (Hematoxylin-eosin
staining); <bold>B.</bold> Decreased interstitial tissue between collagen fibers
and incarceration of eccrine glands and nerves. (Hematoxylin eosin staining)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0075-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Presence of elastic fibers (in dark). (Weigert staining)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0075-g03"/>
      </fig>
      <p>Based on clinical and pathological report was diagnosed with scleroderma, in its variant
nodular/keloid. </p>
      <p>Treatment was started with nifedipine 20 mg/day and aspirin 100 mg/day for Raynaud's
phenomenon. To treat scleroderma nodular lesions we added systemic corticosteroids, oral
methotrexate and phototherapy (PUVA). </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The first report of nodular lesions in patients with scleroderma was done in 1854 by
Thomas Addison; in 1894, Unna called this condition "keloidlike scleroderma".<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup>
Subsequently, in 1904, a number of cases with plaques resembling keloids have been
reported in the German and French literature using the term "tuberous morphea" and in
1913, as "nodular scleroderma".<sup><xref ref-type="bibr" rid="r04">4</xref></sup> In
1954, Korting concluded that the reported cases of scleroderma with nodules or plaques
were different manifestations of the same disease process and this concept was supported
in 1960 by Cabr&#xE9; and Landes, who described both types of lesions in a same
patient.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Since then, "nodular
sclerosis' and "scleroderma keloid" has been used in the literature
interchangeably.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r09">9</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup>
In 2003, Lombadeira <italic>et al</italic>
<sup><xref ref-type="bibr" rid="r04">4</xref></sup> had identified 33 cases descriptions
of such cases in the literature. </p>
      <p>It is known that this form of presentation may overlap both a common form of systemic
and localized SSc; it was also described in previously healthy individuals and in those
with progeria.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref>-<xref ref-type="bibr" rid="r06">6</xref></sup> At present case
we considered a superposition of nodular and limited form of systemic sclerosis. </p>
      <p>Typical lesions can be considered as true exophytic nodules with collagen material that
microscopically show thickened and sclerotic collagen fibers without
fibroblastos.<sup><xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>Nodular sclerosis affects mainly young and middle-aged women.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> The nodules can appear both in regions of normal skin or
in areas already affected by SSc, with preference for the upper limbs, chest, neck,
trunk, abdomen and thighs.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup> Sometimes they assume a linear
distribution.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> The lesions are
painless, although some patients may complain of local itching.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> In general, these lesions appear soon
after diagnosis of SSc when the patient is in the acute phase of cutaneous
lesions.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> It is believed that
they represent an aberrant form of the inflammatory response in patients who have a
tendency to form keloids or in skin sites with high preference for keloids
formation.<sup><xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup> The described patient had an afro-descedent genetic
background, which suggests a greater predisposition to keloidal formation. However the
observation that the nodules usually appear early in the disease has not been verified
in our patient, since she had 12 years of evolution when the nodules appeared. </p>
      <p>Another given explanation for the appearance of nodular form of SSc is that there is
increased activity of TGF-&#xDF;. This is a cytokine which plays a crucial role in collagen
synthesis.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup> It is linked to the stimulation of proliferation
fibroblast, extracellular matrix production, reduction of activities of matrix
metalloproteinases and increase of proteinase inhibitors.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Recently Yamamoto <italic>et al</italic> have also
described increased local expression of CTGF (Connective tissue growth factor) in
nodular scleroderma patients.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> The
formation of CTGF is TGF-&#xDF; induced and its expression has been increased in fibroblasts
from patients with classic forms of SSc.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Response to treatment is poor.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
Several treatment modalities have been tried, among them phototherapy, prednisone,
cefuroxime doxycycline, NSAIDs, cyclosporine.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup> Recently, an <italic>in
vitro</italic> study with imatinib (Gleevec<sup>&#xAE;</sup>) has been shown to reduced
proliferation of dermal fibroblasts in patients with systemic scleroderma.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> PUVA and topical calcipotriol seems to
give a satisfactory response in some lesions.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at the Ambulatorio de Reumato - Dermatologia Hospital Universit&#xE1;rio
Evang&#xE9;lico de Curitiba - Faculdade Evang&#xE9;lica do Paran&#xE1; (HUECFEPAR) - Curitiba (PR),
Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: none</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interests: none</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guidolin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Esmanhotto</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Magro</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Skare</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of cutaneous findings in systemic sclerosis patients -
Experience of a teaching hospital</article-title>
          <source>An Bras Dermatol</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>481</fpage>
          <lpage>486</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wollina</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Looks</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Extracorporeal photochemotherapy in nodular
scleroderma</article-title>
          <source>Br J Dermatol</source>
          <year>1998</year>
          <volume>139</volume>
          <fpage>559</fpage>
          <lpage>560</lpage>
          <pub-id pub-id-type="pmid">9767323</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakashita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nishioka</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Possible role of epidermal growth factor in the lesional skin of
nodular morphea</article-title>
          <source>Acta Derm Venereol</source>
          <year>1998</year>
          <volume>78</volume>
          <fpage>312</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="pmid">9689313</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labandeira</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Le&#xF3;n-Mateos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez-Pe&#xF1;aranda</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Garea</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Toribio</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>What is nodular-keloidal scleroderma</article-title>
          <source>Dermatology</source>
          <year>2003</year>
          <volume>207</volume>
          <fpage>130</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">12920359</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nishioka</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Nodular Scleroderma: Increased Expression of Connective Tissue Growth
Factor</article-title>
          <source>Dermatology</source>
          <year>2005</year>
          <volume>211</volume>
          <fpage>218</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="pmid">16205066</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kauer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Sticherling</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Nodular morphea</article-title>
          <source>Dermatology</source>
          <year>2009</year>
          <volume>218</volume>
          <fpage>63</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">19005241</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cannick 3rd</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Crater</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Nodular scleroderma: case report and literature review</article-title>
          <source>J Rheumatol</source>
          <year>2003</year>
          <volume>30</volume>
          <fpage>2500</fpage>
          <lpage>2502</lpage>
          <pub-id pub-id-type="pmid">14677198</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Junkins-Hopkins</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Sherber</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Wigley</surname>
              <given-names>FM</given-names>
            </name>
          </person-group>
          <article-title>Nodular/Keloidal Scleroderma: Acquired collagenous nodules in systemic
sclerosis</article-title>
          <source>J Rheumatol</source>
          <year>2012</year>
          <volume>39</volume>
          <fpage>660</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="pmid">22383359</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melani</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Caproni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cardinali</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Antiga</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bernacchi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schincaglia</surname>
              <given-names>E</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A case of nodular scleroderma</article-title>
          <source>J Dermatol</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>1028</fpage>
          <lpage>1031</lpage>
          <pub-id pub-id-type="pmid">16471471</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rencic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brinster</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Nousari</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Keloid Morphea and Nodular Scleroderma: Two Distinct Clinical Variants
of Scleroderma?</article-title>
          <source>J Cutan Med Surg</source>
          <year>2003</year>
          <volume>7</volume>
          <fpage>20</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">12362259</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
